CNS Neuroscience & Therapeutics

Cover image for Vol. 22 Issue 11

Edited By: Ding-Feng Su

Impact Factor: 4.019

ISI Journal Citation Reports © Ranking: 2015: 42/253 (Pharmacology & Pharmacy); 65/256 (Neurosciences)

Online ISSN: 1755-5949

Virtual Issues

Virtual Issues from CNS Neuroscience & Therapeutics

Neurodegenerative Diseases

Published: 04 Jan 2012

Edited By: Ding-Feng Su

Efficacy of rivastigmine on executive function in patients with Parkinson's disease dementia.
Schmitt FA, Farlow MR, Meng X, Tekin S, Olin JT.

A double-blind, randomized, placebo and active-controlled study of nebicapone for the treatment of motor fluctuations in Parkinson's disease.
Ferreira JJ, Rascol O, Poewe W, et al.

Apoptosis-inducing factor and cyclophilin a cotranslocate to the motor neuronal nuclei in amyotrophic lateral sclerosis model mice.
Tanaka H, Shimazaki H, Kimura M, et al.

Electroacupuncture Protected Pyramidal Cells in Hippocampal CA1 Region of Vascular Dementia Rats by Inhibiting the Expression of P53 and Noxa.
Zhu Y, Zeng Y.

Potentiation of D-Serine Involves Degeneration of Dopaminergic Neurons in MPTP/p Mouse Model of Parkinson's Disease.
Lu M, Fan Y, Tang M, Qian X, Ding J, Hu G.

Medicinal plants and dementia therapy: herbal hopes for brain aging?
Perry E, Howes MJ.

The multiplicity of action of cannabinoids: implications for treating neurodegeneration.
Gowran A, Noonan J, Campbell VA.

Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data.
Van Laar T, De Deyn PP, Aarsland D, Barone P, Galvin JE.

Genomics and pharmacogenomics of dementia.
Cacabelos R, Mart í nez-Bouza R.

The role of dopamine in symptoms and treatment of apathy in Alzheimer's disease.
Mitchell RA, Herrmann N, Lanctá t KL.

Mapping brain metals to evaluate therapies for neurodegenerative disease.
Gh Popescu BF, Nichol H.

TGF-β Pathway as a new target for neuroprotection in alzheimer's disease.
Caraci F, Battaglia G, Bruno V, et al.

Parkinson's disease dementia and potential therapeutic strategies.
Caviness JN, Lue L, Adler CH, Walker DG.

A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?
Bellingham MC.

Targeting histone deacetylases for the treatment of Huntington's disease.
Gray SG.

Virtual Issues from CNS Neuroscience & Therapeutics


Published: 04 Jan 2012

Edited By: Ding-Feng Su

Increased oxidative stress is responsible for severer cerebral infarction in stroke-prone spontaneously hypertensive rats.
Zhang XH, Lei H, Liu AJ, Zou YX, Shen FM, Su DF

Clots and blots: a stroke of good fortune in identifying protein changes in cerebral accidents.
Laher I

Deficiency of NG2 cells contributes to the susceptibility of stroke-prone spontaneously hypertensive rats
Wang P, Tian WW, Song J, Guan YF, Miao CY

From hypertension to stroke: mechanisms and potential prevention strategies.
Yu JG, Zhou RR, Cai GJ

Insulin-like growth factor -1 (IGF-1) derived neuropeptides, a novel strategy for the development of pharmaceuticals for managing ischemic brain injury.
Guan J.

Role of Intracranial Microaneurysm in the Pathogenesis of Stroke in SHR-SP.
Yang C, Yu JG, Liu JG, Cai GJ, Su DF.

Cerebral artery remodeling in stroke-prone spontaneously hypertensive rats.
Yang C, Zhang X, Song SW, Yu JG, Cai GJ.

A new index to predict the incidence of cerebral infarction.
Hao CN, Huang ZH, Shi YQ, Lu W, Duan JL.